Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | roundabout 2 | 0.0277 | 0.9136 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.8997 | 0.8997 |
Loa Loa (eye worm) | hypothetical protein | 0.0277 | 0.9136 | 0.9136 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.8997 | 0.8997 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0277 | 0.9136 | 0.9136 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.8997 | 0.8997 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0738 | 0.0738 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0738 | 0.0738 |
Brugia malayi | hypothetical protein | 0.0277 | 0.9136 | 0.9136 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.8997 | 0.8997 |
Loa Loa (eye worm) | hypothetical protein | 0.0277 | 0.9136 | 0.9136 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0299 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0277 | 0.9136 | 0.9136 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0738 | 0.0738 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0273 | 0.8997 | 0.9847 |
Schistosoma mansoni | nephrin | 0.0277 | 0.9136 | 1 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0273 | 0.8997 | 0.9847 |
Schistosoma mansoni | cell adhesion molecule | 0.0277 | 0.9136 | 1 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0277 | 0.9136 | 0.9136 |
Echinococcus multilocularis | roundabout 2 | 0.0277 | 0.9136 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.8997 | 0.8997 |
Loa Loa (eye worm) | hypothetical protein | 0.0273 | 0.8997 | 0.8997 |
Schistosoma mansoni | vesicular amine transporter | 0.0273 | 0.8997 | 0.9847 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0738 | 0.0738 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.